|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$107,746
|
N/A
|
National Institutes of Health
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
$42,233
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,704,173
|
$735,209
|
Custer, Mary
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA008748-48
|
$12,352,942
|
$370,588
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Regional Oncology Research Center
|
5P30CA006973-51
|
$6,785,409
|
$67,854
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-26
|
$5,914,688
|
$118,294
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
Mayo Comprehensive Cancer Center Grant
|
2P30CA015083-40
|
$5,569,750
|
$55,698
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Cancer Center Support Grant
|
5P30CA047904-26
|
$4,985,360
|
$99,707
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA016058-38
|
$4,444,835
|
$400,035
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,436,451
|
$221,823
|
Gulley, James
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-40
|
$4,421,130
|
$88,423
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$107,557
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Cancer Center Support Grant
|
5P30CA046934-26
|
$3,486,683
|
$209,201
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
|
5P01CA124570-07
|
$2,176,488
|
$2,176,488
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE
|
5P50CA168505-02
|
$2,162,002
|
$2,162,002
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
SPORE in Thyroid Cancer
|
1P50CA172012-01A1
|
$2,008,466
|
$2,008,466
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-28
|
$1,485,000
|
$14,850
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
OSU as Network Lead Academic Participating Site for the NCI NCTN
|
1U10CA180850-01
|
$1,455,849
|
$36,396
|
GOLDBERG, RICHARD
|
OHIO STATE UNIVERSITY
|
|
Agricultural Health Study - BioMarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 - 10527
|
$1,102,766
|
$110,277
|
Alavanja, Michael
|
DCEG (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 - 03152
|
$1,076,623
|
$53,831
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
|
ZIA BC 011337
|
$1,037,081
|
$259,270
|
Yang, James
|
CCR (NCI)
|
|
EOB Clinical Core
|
ZID BC 011534
|
$884,924
|
$221,231
|
Kebebew, Electron
|
CCR (NCI)
|
|
Genomic and genetic studies of endocrine cancers
|
ZIA BC 011275
|
$829,616
|
$414,808
|
Kebebew, Electron
|
CCR (NCI)
|
|
Therapeutic targets and novel anticancer agents for endocrine cancers
|
ZIA BC 011286
|
$829,616
|
$414,808
|
Kebebew, Electron
|
CCR (NCI)
|
|
Novel High Affinity VEGF Analogs For Targeted Imaging of Thyroid Cancer
|
4R44CA171352-02
|
$825,054
|
$825,054
|
WEINTRAUB, BRUCE
|
TROPHOGEN, INC.
|
|
DICER1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
|
ZIA CP010144 - 10548
|
$799,827
|
$39,991
|
Stewart, Douglas
|
DCEG (NCI)
|
|
Chornobyl Thyroid Study (Ukraine)
|
ZIA CP010132 - 04173
|
$767,140
|
$767,140
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
NCI NCTN- Network Lead Academic Participating Site: USC
|
1U10CA180830-01
|
$629,001
|
$31,450
|
LENZ, HEINZ JOSEF
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Development of breakthrough intra-operative detector and imaging system for parat
|
9R42CA192243-02A1
|
$591,600
|
$396,372
|
MAHADEVAN-JANSEN, ANITA
|
ANASYS INSTRUMENTS CORPORATION
|
|
Yale Cancer Center NCTN
|
1U10CA180826-01
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133 - 04180
|
$538,069
|
$80,710
|
Linet, Martha
|
DCEG (NCI)
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 - 02020
|
$529,634
|
$26,482
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Preclinical Mouse Model of Thyroid Carcinogenesis
|
ZIA BC 011191
|
$519,474
|
$415,579
|
Cheng, Sheue-yann
|
CCR (NCI)
|
|
Chornobyl Thyroid Study (Belarus)
|
ZIA CP010132 - 04019
|
$510,324
|
$510,324
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
TGIB Surgical Oncology Fellowship Program
|
ZIE BC 011542
|
$498,512
|
$24,926
|
Schrump, David
|
CCR (NCI)
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$483,032
|
$48,303
|
Widemann, Brigitte
|
CCR (NCI)
|
|
In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancer
|
5R01CA166033-02
|
$481,093
|
$481,093
|
KOENIG, RONALD
|
UNIVERSITY OF MICHIGAN
|
|
Cancer Mortality among Military Participants at U.S. Nuclear Weapons Tests
|
5U01CA137026-05
|
$453,162
|
$45,316
|
BOICE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Thyroid Stem/Progenitor Cells
|
ZIA BC 005522
|
$417,497
|
$417,497
|
Kimura, Shioko
|
CCR (NCI)
|
|
Maximizing effectiveness of radioiodine therapy by inhibition of MAPK signaling
|
5R01CA173592-02
|
$402,117
|
$402,117
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Shanghai prospective cohort study of occupational exposures and cancer risk among women
|
ZIA CP010123 - 02342
|
$390,592
|
$19,530
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
Improved diagnostic and monitoring assays for thyroid cancer
|
5R44CA150324-03
|
$390,222
|
$390,222
|
PILLER, KENNETH
|
SOYMEDS, INC.
|
|
Molecular Pathophysiology of Thyroid Cell Growth
|
5R01CA050706-24
|
$379,852
|
$379,852
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Central Neck Dissection in Patients with Clinical Node Negative Thyroid Cancer
|
1R01CA176911-01A1
|
$378,091
|
$378,091
|
SIPPEL, REBECCA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Predictive MRI metrics for tumor aggressiveness in micropapillary thyroid cancer
|
1R21CA176660-01A1
|
$368,728
|
$368,728
|
DAVE, AMITA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
BRAFV600E and VEGFR2 synergize to trigger papillary thyroid cancer progression
|
1R01CA181183-01A1
|
$361,050
|
$361,050
|
NUCERA, CARMELO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Theranostic nanoparticles for the treatment of RAI refractory thyroid cancer
|
5R01CA178007-02
|
$341,162
|
$341,162
|
JIN, MOONSOO
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
|
5R01CA167839-02
|
$336,129
|
$336,129
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Regional Oncology Research Center
|
3P30CA006973-51S3
|
$324,000
|
$3,240
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
RCAN1 in Thyroid Cancer Progression
|
5R01CA152066-04
|
$321,307
|
$321,307
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
Total relevant funding to Thyroid for this search: $23,070,505
|